Journals / Çocuk Dergisi / 2016 / Cilt: 16 - Sayı: 2

Approach to Thrombocytophenia in Children

Çocuklarda Trombositopeniye Yaklaşım

Pages
67–73
Publication Date
2016-07-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Peripheral blood smear is the gold standard diagnostic approach for quantitative, and morp- hological evaluation of number, morphology and clustering of platelets and other blood elements as well

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Platelets are the key elements that are responsible for pri- mary hemostasis.
📊
Key Findings & Data:When absolute number of platelets in peripheral blood is less than 150000/mm3, it is called thrombocytopenia.
💡
Conclusion & Impact:Peripheral blood smear is the gold standard diagnostic approach for quantitative, and morp- hological evaluation of number, morphology and clustering of platelets and other blood elements as well
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Çocuk · trombositopeni · periferik yayma

Abstract

Platelets are the key elements that are responsible for pri- mary hemostasis. When absolute number of platelets in peripheral blood is less than 150000/mm3, it is called thrombocytopenia. Detailed anamnesis, complete physical examination and a laboratory evaluation including perip- heral blood smear are vital when approaching to throm- bocytopenic patients. Peripheral blood smear is the gold standard diagnostic approach for quantitative, and morp- hological evaluation of number, morphology and clustering of platelets and other blood elements as well

Özet

Trombositler primer hemostazda görevli ana elemanlardır. Trombosit sayısının 150.000/mm3’den düşük olmasına trombositopeni denir. Trombositopenik hastaya yaklaşımda detaylı öykü alınması, tam fizik muayene yapılması ve labo- ratuar değerlendirmede periferik yaymanın kesinlikle ince- lenmsi gerekir. Trombositlerin sayı ve morfolojisi, küme oluşturması, diğer kan elemanlarının sayısal ve morfolojik değerlendirlmesi için periferik yayma tanısal yaklaşımda altın standarttır

🔖

Cite This Article

AYDOĞDU, S., KARAMAN, S., KARAKAŞ, Z. (2016). Approach to Thrombocytophenia in Children. Çocuk Dergisi, Cilt: 16 - Sayı: 2, 67–73. https://ajindex.com/articles/247048

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Beyan C, nevruz o. Kanama ve tromboz (Çeviri). Harrison İç Hastalıkları Prensipleri (Çeviri). Çeviri Editörü: Yahya Sağlıker. Cilt 1, 15. Edisyon, Nobel Tıp Kitabevleri, 2004: 354-60.
  2. McGuinn C, Bussel JB. Disorders of platelets. Lanzkowsky’s manual of pediatric hematology and oncology. Sixth Edition 2016;239-278. https://doi.org/10.1016/B978-0-12-801368-7.00014-4 Kılınç Y. Trombositopenilerde tanısal yaklaşım (Algoritma). Türk Pediatrik Hematoloji Derneği, TPHD Eğitim Serisi-IV, Trombosit Hastalıkları. Galenos Yayıncılık, 2017;31-34.
  3. Liu Y, Chen S, Sun Y, Lin Q, Liao X, Zhang J, et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study. Medicine (Baltimore) 2016;95:5565. https://doi.org/10.1097/MD.0000000000005565 Choi SI, mcClure Pd. Idiopathic thrombocytopenic purpura in childhood. Can Med Assoc J 1967;97:562- 568. Franchini m. The platelet-function analyzer (PFA– 100®) for evaluating primary hemostasis. Hematology 2005;10:177-81. https://doi.org/10.1080/10245330400026097 drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 2004;103:390-8. https://doi.org/10.1182/blood-2003-05-1742 Wilon DB. Acquired platelet disorders. In Nathan and Oski’s Hematology of infancy and childhood. 7th edition. 2009;1553-1590. Albert mH, noterangelo Ld, occhs Hd. Clinical spectrum, pathophysiology and treatment of theWiskott- Aldrich syndrome. Curr Opin Hematol 2011;18:42-8. https://doi.org/10.1097/MOH.0b013e32834114bc
  4. Evans rS, Takahashi K, duane rT. Primary throm- bocytopenic purpura and acquired haemolytic anemia. Arch Int Med 1951;87:48-65. https://doi.org/10.1001/archinte.1951.03810010058005
  5. Aul C, Giagounidis A, et al. Evaluating the prognosis of patients with myelodysplastic syndromes. Review article. Ann Hematol 2002;81:485-97. https://doi.org/10.1007/s00277-002-0530-z nakao S, Ishiyama K. Hypomegakaryocytic throm- bocytopenia and increased number of PNH-phenotype cells-an emerging subgroup of myelodysplastic syndro- me showing frequent response to immunosuppression- Response to Refferr to Rafferty&Leach. Correspon- dence. Br J Haematol 2017; 14755. https://doi.org/10.1111/bjh.14755 Bussel JB. Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemos 2001;27:245-52. https://doi.org/10.1055/s-2001-15254 roberts I, Stanworth S, murray nA. Thrombocyto- phenia in neonate. Blood Rev 2008;22:173-86. https://doi.org/10.1016/j.blre.2008.03.004
  6. WongW, Glader B. Ap